OTC : KKPCF

Kaken Pharmaceutical Co., Ltd.

$26 USD

$0 (0.0%)

Volume
2
Average Volume
1.8
Market Capitalization
$984.58M
P/E Ratio
68.23
Dividend Yield
4.92%
Price Target
Year High
$28.12
Year Low
$22.30
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.52
3333332"{? p/.m7yd f,0=

Annual earnings financials

KKPCF financial data with annual/quarterly toggle

KKPCF GAAP EPS - Annual & Quarterly

KKPCF Sales Revenue - Annual & Quarterly

KKPCF Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

KKPCF Estimated and Actual Revenue by Quarter
KKPCF Estimated and Actual EPS by Quarter
KKPCF Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-03-31 1 3.58B 3.58B 3.58B 2.78B 2.78B 2.78B
2025-12-31 1 3.04B 3.04B 3.04B 2.36B 2.36B 2.36B
2025-09-30 1 4.29B 4.29B 4.29B 3.61B 3.61B 3.61B
2025-06-30 1 3.9B 3.9B 3.9B 3.28B 3.28B 3.28B
KKPCF Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-03-31 1 761.89M 761.89M 761.89M 5B 5B 5B
2025-12-31 1 940.02M 940.02M 940.02M 4.25B 4.25B 4.25B
2025-09-30 1 - - - 4.39B 4.39B 4.39B
2025-06-30 1 - - - 3.99B 3.99B 3.99B
KKPCF Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-03-31 1 22.83B 22.83B 22.83B 1 20.11059 20.11059 20.11059
2025-12-31 1 19.39B 19.39B 19.39B 1 24.81249 24.81249 24.81249
2025-09-30 1 20.78B 20.78B 20.78B 0 0 0 0
2025-06-30 1 18.87B 18.87B 18.87B 0 0 0 0